that is an incorrect statement, many patents will also cover hernia and breast and various other products in development. As such what are you saying is completely incorrect. I do not know when BTM MTX expires but for sure it is before 2038, my key point being sometimes after 2028 expect large pharmaceuticals to enter post the first patent expiry to market some polymer competing product(s). Even if they just start today or even later with their well resourced and staffed R&D division, it can be easily done. Don’t just put your head in the sand and pretend it won’t happen
- Forums
- ASX - By Stock
- PNV
- Ann: PolyNovo presents at Evans & Partners Healthcare Conference
Ann: PolyNovo presents at Evans & Partners Healthcare Conference, page-8
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.33 |
Change
-0.020(0.85%) |
Mkt cap ! $1.601B |
Open | High | Low | Value | Volume |
$2.32 | $2.34 | $2.29 | $1.248M | 539.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40 | $2.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.10 | 2 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 24056 | 2.330 |
18 | 49683 | 2.320 |
19 | 41960 | 2.310 |
21 | 118019 | 2.300 |
13 | 23268 | 2.290 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 24255 | 24 |
2.350 | 60779 | 16 |
2.360 | 67889 | 15 |
2.370 | 142045 | 11 |
2.380 | 11999 | 6 |
Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online